Silk Road Medical (Nasdaq:SILK) announced today that it launched its tapered EnRoute transcarotid stent system in the U.S. Sunnyvale, California-based Silk Road says this expands upon the prior launch of its EnRoute system by adding additional configurations. It better tailors the transcarotid artery revascularization (TCAR) procedure to the patient anatomy. TCAR, a minimally invasive procedure, […]
Silk Road Medical
Silk Road Medical names a new CEO
Silk Road Medical (Nasdaq:SILK) announced today that it appointed Chas McKhann as its new CEO, effective immediately. Located in Sunnyvale, California and Plymouth, Minnesota, Silk Road Medical is focused on reducing stroke risk through a carotid artery disease treatment called TransCarotid Artery Revascularization (TCAR). The company announced last month that CEO Erica Rogers intended to […]
Silk Road Medical CEO announces retirement
Silk Road Medical (Nasdaq:SILK) today announced that CEO Erica Rogers plans to retire from the company. Rogers will formally retire once the succession process is completed. The Sunnyvale, California-based company is working with executive search firm Spencer Stuart to find a replacement CEO. “I’d like to thank Erica for her tremendous contributions to Silk Road […]
Silk Road Medical ticks up on Street-beating Q3 results
Silk Road Medical (NSDQ:SILK) this week posted third-quarter results that beat the overall consensus on Wall Street. The Sunnyvale, California-based stroke treatment tech company reported net losses of $10.3 million, or -29¢ per share, on sales of $37.4 million for the three months ended Sept. 30, on sales growth of 51.31% and profit gain from […]
Silk Road Medical announces $100M offering
Silk Road Medical (NSDQ:SILK) announced that it commenced a proposed underwritten public offering of $100 million in common stock. The Sunnyvale, California–based stroke treatment tech company plans to use proceeds to expand its sales force and operations. It also intends to increase its R&D activities, conduct or sponsor clinical trials and lease new facilities. Silk […]
Silk Road Medical grows sales 27% in Q1 results
Silk Road Medical (NSDQ:SILK) this week posted first-quarter results that beat the revenue consensus on Wall Street and missed on earnings. The Sunnyvale, California-based stroke treatment tech company reported losses of $16.7 million, or -48¢ per share, on sales of $28.02 million for the three months ended March 31 for sales growth of 27% compared […]
Silk Road Medical grows sales 33% in Q4
Silk Road Medical (NSDQ:SILK) posted fourth-quarter results that beat the revenue consensus on Wall Street and missed on earnings estimates. The Sunnyvale, California-based stroke treatment tech company reported losses of -$14.7 million, or -42¢ per share, on sales of $28.3 million for the three months ended Dec. 31, 2021, for a bottom-line gain of 12.3% […]